Dow Up 0.35% Nasdaq Down 0.02%

More On LRUSF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Lorus Therapeutics Inc. (LRUSF)

-Other OTC
0.40 Aug 19, 12:48PM EDT
|Pre-Market : NaN
Prev Close:0.40
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:1.83
Beta:-0.11
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.17 - 0.93
Volume:0
Avg Vol (3m):9,706
Market Cap:55.21M
P/E (ttm):N/A
EPS (ttm):-0.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LRUSF

Comparison

Symbol% ChgMkt Cap
LRUSF 0.00%55.21M
BMY82.96B
ISIS4.15B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (May-15) :-0.13
Quarterly EPS Est (Aug-14) :-0.03
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Lorus Therapeutics Inc., a biopharmaceutical company, is engaged in the discovery, research, and development of novel anticancer therapies in Canada. The company’s pipeline of cancer drug candidates includes small molecule therapies and immun... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback